CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
NCT07106749
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
B Acute Lymphoblastic Leukemia/Lymphoma
Interventions
BIOLOGICAL:
CD180 CART
Sponsor
Institute of Hematology & Blood Diseases Hospital, China